HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jun-O Jin Selected Research

Insulin Resistance

6/2021Dipeptidyl Peptidase (DPP)-IV Inhibitors with Antioxidant Potential Isolated from Natural Sources: A Novel Approach for the Management of Diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jun-O Jin Research Topics

Disease

47Neoplasms (Cancer)
11/2022 - 03/2008
11Neoplasm Metastasis (Metastasis)
05/2022 - 04/2016
11Inflammation (Inflammations)
02/2022 - 02/2013
6Carcinoma (Carcinomatosis)
05/2022 - 12/2017
6Melanoma (Melanoma, Malignant)
07/2021 - 04/2016
5Breast Neoplasms (Breast Cancer)
05/2022 - 01/2014
4Lung Neoplasms (Lung Cancer)
09/2021 - 01/2021
4Experimental Melanoma
03/2021 - 04/2016
4Septic Shock (Toxic Shock Syndrome)
03/2020 - 12/2016
3Communicable Diseases (Infectious Diseases)
02/2022 - 02/2015
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021 - 01/2020
3Infections
01/2020 - 10/2014
3Leukemia
06/2009 - 01/2007
2Lewis Lung Carcinoma
05/2022 - 09/2021
2Hyperglycemia
06/2021 - 01/2020
2Sepsis (Septicemia)
03/2020 - 01/2019
2Stomach Neoplasms (Stomach Cancer)
01/2019 - 03/2018
2HIV Infections (HIV Infection)
01/2017 - 01/2017
2Sialadenitis
12/2015 - 08/2013
2Endometriosis
06/2011 - 09/2009
1Autoimmune Diseases (Autoimmune Disease)
01/2022
1Type 2 Diabetes Mellitus (MODY)
06/2021
1Insulin Resistance
06/2021
1Hypoglycemia (Reactive Hypoglycemia)
06/2021
1COVID-19
01/2021
1Carcinogenesis
01/2021
1Osteoporosis
12/2020

Drug/Important Bio-Agent (IBA)

15Polysaccharides (Glycans)IBA
02/2022 - 08/2010
14Proteins (Proteins, Gene)FDA Link
09/2021 - 01/2014
13AntigensIBA
05/2022 - 01/2014
9fucoidanIBA
05/2022 - 08/2010
6Immune Checkpoint InhibitorsIBA
11/2022 - 03/2021
6OvalbuminIBA
09/2020 - 04/2016
5AutoantigensIBA
05/2022 - 12/2018
4Therapeutic UsesIBA
05/2022 - 02/2018
4Poly I-CIBA
05/2022 - 03/2013
4Pharmaceutical PreparationsIBA
01/2021 - 03/2017
4CytokinesIBA
09/2020 - 08/2013
4LipopolysaccharidesIBA
03/2020 - 12/2016
4Interleukin-7 (Interleukin 7)IBA
12/2015 - 03/2013
3Indocyanine Green (Cardio-Green)FDA LinkGeneric
05/2022 - 01/2019
3UbiquitinIBA
01/2022 - 01/2021
3LigandsIBA
09/2021 - 03/2013
3Antineoplastic Agents (Antineoplastics)IBA
05/2021 - 03/2008
3porphyranIBA
03/2020 - 12/2016
3Monophenol Monooxygenase (Tyrosinase)IBA
01/2020 - 07/2016
3InterferonsIBA
01/2020 - 06/2017
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020 - 08/2013
2Nucleic AcidsIBA
11/2022 - 01/2020
2laminaranIBA
05/2022 - 06/2017
2HydrogelsIBA
05/2022 - 01/2020
2Toll-Like Receptor 4IBA
03/2021 - 01/2017
2AntibodiesIBA
03/2021 - 01/2020
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 01/2019
2Biomarkers (Surrogate Marker)IBA
04/2020 - 01/2020
2EndotoxinsIBA
03/2020 - 02/2020
2PrionsIBA
01/2020 - 01/2020
2InterleukinsIBA
01/2020 - 12/2015
2Amyloid (Amyloid Fibrils)IBA
01/2020 - 01/2020
2DNA (Deoxyribonucleic Acid)IBA
12/2019 - 09/2017
2LipidsIBA
12/2019 - 09/2017
2PolymersIBA
08/2019 - 02/2018
2peptide SVYDFFVWLIBA
12/2018 - 07/2016
2cupric sulfide (CuS)IBA
02/2018 - 12/2017
2VaccinesIBA
09/2017 - 02/2015
2AutoantibodiesIBA
08/2013 - 02/2013
2AgarIBA
04/2010 - 03/2008
1Immune Checkpoint ProteinsIBA
11/2022
1B7-H1 AntigenIBA
05/2022
1AlginatesIBA
05/2022
1CollagenIBA
05/2022
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2022
1Programmed Cell Death 1 ReceptorIBA
01/2022
1Cancer VaccinesIBA
01/2022
1GoldIBA
01/2022
1CarbohydratesIBA
06/2021
1Dipeptidyl-Peptidase IV InhibitorsIBA
06/2021
1Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
06/2021
1Glucose (Dextrose)FDA LinkGeneric
06/2021
1FucoseIBA
05/2021
1monophosphoryl lipid AIBA
03/2021
1Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA
03/2021
1DisulfidesIBA
01/2021
1Recombinant ProteinsIBA
01/2021
1Ligases (Synthetase)IBA
01/2021
1Biocompatible Materials (Biomaterials)IBA
01/2021
1Escherichia coli AdhesinsIBA
01/2021
1Tripartite Motif-Containing Protein 28IBA
01/2021
1Dental Implants (Dental Implant)IBA
12/2020
1Estrogens (Estrogen)FDA Link
12/2020
1Dextran SulfateIBA
09/2020

Therapy/Procedure

19Immunotherapy
11/2022 - 01/2017
17Therapeutics
11/2022 - 04/2016
8Photothermal Therapy
11/2022 - 12/2017
6Lasers (Laser)
01/2022 - 12/2017
4Drug Therapy (Chemotherapy)
11/2022 - 03/2017
3Intranasal Administration
09/2021 - 07/2021
1Radiotherapy
11/2022
1Injections
05/2022
1Ovariectomy (Oophorectomy)
12/2020